138 related articles for article (PubMed ID: 37544256)
1. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration.
Jacobs MR; Olivero JE; Ok Choi H; Liao CP; Kashemirov BA; Katz JE; Gross ME; McKenna CE
Bioorg Med Chem; 2023 Sep; 92():117425. PubMed ID: 37544256
[TBL] [Abstract][Full Text] [Related]
2. Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
Gaur S; Gross ME; Liao CP; Qian B; Shih JC
Prostate; 2019 May; 79(6):667-677. PubMed ID: 30693539
[TBL] [Abstract][Full Text] [Related]
3. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
[TBL] [Abstract][Full Text] [Related]
4. Targeting monoamine oxidase A in advanced prostate cancer.
Flamand V; Zhao H; Peehl DM
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1761-71. PubMed ID: 20204405
[TBL] [Abstract][Full Text] [Related]
5. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
Wooters TE; Bardo MT
Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
7. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms.
Upadhyay AK; Wang J; Edmondson DE
Biochemistry; 2008 Jan; 47(2):526-36. PubMed ID: 18092818
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.
Li PC; Siddiqi IN; Mottok A; Loo EY; Wu CH; Cozen W; Steidl C; Shih JC
J Pathol; 2017 Oct; 243(2):220-229. PubMed ID: 28722111
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monoamine oxidase by clorgyline analogues.
O'Brien EM; Tipton KF; Meroni M; Dostert P
J Neural Transm Suppl; 1994; 41():295-305. PubMed ID: 7931241
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary crystallographic analysis of rat monoamine oxidase A complexed with clorgyline.
Ma J; Kubota F; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):317-9. PubMed ID: 14747710
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
Chenu F; El Mansari M; Blier P
Int J Neuropsychopharmacol; 2009 May; 12(4):475-85. PubMed ID: 18700056
[TBL] [Abstract][Full Text] [Related]
13. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
Wang K; Luo J; Yeh S; You B; Meng J; Chang P; Niu Y; Li G; Lu C; Zhu Y; Antonarakis ES; Luo J; Huang CP; Xu W; Chang C
Nat Commun; 2020 Jun; 11(1):2689. PubMed ID: 32483206
[TBL] [Abstract][Full Text] [Related]
14. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of the active site of brain monoamine oxidase.
Youdim MB
Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells.
Zhao H; Nolley R; Chen Z; Reese SW; Peehl DM
Differentiation; 2008 Sep; 76(7):820-30. PubMed ID: 18248494
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of enantiomerically pure pyrrolyl-oxazolidinones as a new class of potent and selective monoamine oxidase type A inhibitors.
Mai A; Artico M; Esposito M; Ragno R; Sbardella G; Massa S
Farmaco; 2003 Mar; 58(3):231-41. PubMed ID: 12620419
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]